TY  - GEN
AU  - Mikulski,Stanislaw M
AU  - Costanzi,John J
AU  - Vogelzang,Nicholas J
AU  - McCachren,Spence
AU  - Taub,Robert N
AU  - Chun,Hoo
AU  - Mittelman,Abraham
AU  - Panella,Timothy
AU  - Puccio,Carmelo
AU  - Fine,Robert
AU  - Shogen,Kuslima
TI  - Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma
SN  - 0732-183X
PY  - 2002///0201
KW  - Aged
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Female
KW  - Humans
KW  - Infusions, Intravenous
KW  - Male
KW  - Mesothelioma
KW  - drug therapy
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Proportional Hazards Models
KW  - Ribonucleases
KW  - Statistics, Nonparametric
KW  - Survival Rate
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2002.20.1.274
ER  -